Skip to main content
logo
Marker Therapeutics, Inc. (MRKR)
NASDAQ: MRKR · Real-Time Price · USD
1.220
-0.050 (-3.94%)
Jul 24, 2026, 4:00 PM EDT - Market closed

Marker Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
3.23.556.593.319.011.24
Revenue Growth
-43.86%-46.19%99.06%-63.27%625.90%166.01%
Gross Profit
3.23.556.593.319.011.24
Operating Income
-12.35-12.89-11.12-14.58-29.95-39.48
Net Income
-10.9-12.16-10.73-8.24-29.93-41.88
Earnings Per Share
-0.61-0.79-1.19-0.94-3.58-5.47
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
14.9216.0719.1915.1111.7842.35
Total Debt
0000011.87
Net Cash (Debt)
14.9216.0719.1915.1111.7830.48
Net Cash Growth
8.93%-16.28%27.01%28.26%-61.35%235.15%
Net Cash Per Share
0.861.052.141.721.413.98

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-7.92-12.01-10.91-16.44-26.97-27.28
Capital Expenditures
-----4.95-3.13
Free Cash Flow
-7.92-12.01-10.91-16.44-31.92-30.41
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%
Operating Margin
-386.37%-363.45%-168.69%-440.37%-332.23%-3179.32%
Pretax Margin
-364.76%-343.39%-162.06%-424.09%-332.06%-3372.68%
Profit Margin
-364.76%-342.96%-162.82%-424.20%-332.06%-3372.68%
FCF Margin
-247.64%-338.74%-165.53%-496.51%-354.10%-2449.11%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
5.747.005.0514.772.4763.57